Several clinical trials are currently underway for Sjögren’s syndrome. – The Quebec Public Clinical Trials Registry, developed by SemiWeb via the Nagano platform, allows you to identify clinical trials that are currently (or have been, or will soon be) conducted in Quebec, Canada, and around the world. The Registry compiles and shares, in real time, data from the computer system used by public institutions in Quebec’s health and social services network (the Nagano system) and data from ClinicalTrials.gov (an international public registry).   Learn more…

ILD-SARDs Registry and Biobank* – The purpose of this biobank is to study the clinical, pathological, laboratory, and imaging characteristics of SARDs patients with lung involvement. This will help identify unique characteristics underlying pulmonary involvement in SARDs (Systemic Autoimmune Rheumatic Diseases). In addition, it may lead to the discovery of new disease mechanisms and potentially new treatment targets for SARDs patients with lung disease. A complex interaction between demographic, environmental, and genetic mechanisms impacts the onset, severity, and outcome of ILD-SARDs through dysregulation of the immune system and pulmonary probiotic pathways. Comorbidity and genetic risk indicate that there are overlapping pathogenic mechanisms among SARDs, some of which underlie ILD in different SARDs. Learn more…

*(SARDs : Systemic Autoimmune Rheumatic Diseases) Maladies Rhumatismales Auto-immunes Systémiques – (LD : Interstitial lung disease) Maladie Pulmonaire Intertielle (MPI).

Quebec Clinical Research: A resource that supports you throughout your search for clinical trials.  Learn more…